The biotechnology sector in India has rapidly evolved into a global hub for innovation, manufacturing, and cutting-edge research. As the world’s third-largest biotech destination, India is shaping the future of biosimilars, vaccine development, CROs, CRDMOs, and advanced R&D.
Now, with the BIO International Convention 2025 set to take place in Boston from June 16-19, Indian companies have an unparalleled opportunity to showcase their expertise on the global stage.
To amplify this momentum, BioVoice News and the International Contract Pharma Association (ICPA) have collaborated to present India Biotech Outlook 2025: The India Advantage – A Thriving Ecosystem for Global Business. This exclusive publication will highlight India’s leadership in biotech and provide a powerful platform for companies to maximize their presence at BIO 2025.
Why This Publication Matters?
BIO 2025 is the world’s most comprehensive biotech gathering, attracting 20,000+ industry leaders, investors, and policymakers from around the globe. India Biotech Outlook 2025 will serve as a strategic knowledge resource, showcasing business trends, technology advancements, R&D breakthroughs, sustainability initiatives, and investment opportunities in India’s biotech sector.
A Unique Opportunity for Indian Companies
For Exhibitors at BIO 2025:
Being at BIO 2025 is a major step toward global visibility. But how do you ensure that your presence stands out among thousands of companies? Featuring in India Biotech Outlook 2025 will:
-
Amplify your brand visibility before and duringthe event.
-
Position you as a thought leaderin biotech innovation.
-
Offer exclusive benefits, including a founder’s photo on the cover & logo on the back page(for two-page advertisers).
-
Ensure direct reach to key stakeholders, investors, and global decision-makers.
 have collaborated to present an exclusive publication that will highlight India’s leadership in biotech and provide a powerful platform for companies to maximize their presence){kind=link}